Detection of recurrent phosphaturic mesenchymal tumors by using Ga-68 DOTATATE PET/CT-Reference-Cited by-同舟云学术

Detection of recurrent phosphaturic mesenchymal tumors by using Ga-68 DOTATATE PET/CT

Published:2024-01-04 Issue:1 Volume:10 Page:144-148
ISSN:2149-3189
Container-title:The European Research Journal
language:
Short-container-title:

Author:

ASHFAQ Wardah¹^ORCID,IFTIKHAR Iqra¹^ORCID,FAYYAZ Mariam¹^ORCID,KHIZER Mahnam¹^ORCID,FATIMA Saira²^ORCID,YOUNİS Muhammad Numaır¹^ORCID

Affiliation:

1. Department of Nuclear Medicine and PET Imaging, Institute of Nuclear Medicine and Oncology, Lahore, Pakistan

2. Department of Histopathology, Agha Khan University, Karachi, Pakistan

Abstract

Phosphaturic mesenchymal tumor is a rare clinical condition and often causes osteomalacia due to tumor. Its diagnosis is often significantly delayed due to its rare occurrence in addition to the generalized and vague symptoms of their presentation. A 19-year-old female with a history of left facial nerve palsy, generalized weakness and hoarseness of voice revealed a dense mass in her brain. In this case, we reported successful application of a Ga-68 labeled DOTATATE PET/CT scan to identify the primary site and distant metastases of phosphaturic mesenchymal tumors and show the diagnostic value of Ga-68 labeled DOTATATE PET/CT imaging for the rare tumors.

Publisher

The European Research Journal

Subject

General Medicine

Reference12 articles.

1. 1. Ghorbani-Aghbolaghi A, Darrow MA, Wang T. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss. Autops Case Rep. 2017;7(3):32-37. doi: 10.4322/acr.2017.031.

2. 2. Brandi ML, Clunie GPR, Houillier P, et al. Challenges in the management of tumor-induced osteomalacia (TIO). Bone. 2021;152:116064. doi: 10.1016/j.bone.2021.116064.

3. 3. Lee DY, Lee SH, Kim BJ, et al. Usefulness of 68Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia. Sci Rep. 2021;11(1):1819. doi: 10.1038/s41598-021-81491-2.

4. 4. Moreno Romero M, Pérez Muñoz I, González Lizán F, Gallego Rivera JI, Valdivielso Cañas L. The phosphaturic mesenchymal tumor as a cause of oncogenic osteomalacia. Three cases and review of the literature. Rev Esp Cir Ortop Traumatol (Engl Ed). 2021:S1888-4415(21)00050-3. doi: 10.1016/j.recot.2020.12.004.

5. 5. Qiu S, Cao LL, Qiu Y, et al . Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report. Medicine (Baltimore). 2017;96(17):e6750. doi: 10.1097/MD.0000000000006750.